» Articles » PMID: 20062797

Immature Dengue Virus: a Veiled Pathogen?

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2010 Jan 12
PMID 20062797
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Cells infected with dengue virus release a high proportion of immature prM-containing virions. In accordance, substantial levels of prM antibodies are found in sera of infected humans. Furthermore, it has been recently described that the rates of prM antibody responses are significantly higher in patients with secondary infection compared to those with primary infection. This suggests that immature dengue virus may play a role in disease pathogenesis. Interestingly, however, numerous functional studies have revealed that immature particles lack the ability to infect cells. In this report, we show that fully immature dengue particles become highly infectious upon interaction with prM antibodies. We demonstrate that prM antibodies facilitate efficient binding and cell entry of immature particles into Fc-receptor-expressing cells. In addition, enzymatic activity of furin is critical to render the internalized immature virus infectious. Together, these data suggest that during a secondary infection or primary infection of infants born to dengue-immune mothers, immature particles have the potential to be highly infectious and hence may contribute to the development of severe disease.

Citing Articles

Nano-interventions for dengue: a comprehensive review of control, detection and treatment strategies.

Shaikh S, Sandeep Chary P, Mehra N Inflammopharmacology. 2025; .

PMID: 39976669 DOI: 10.1007/s10787-025-01655-8.


Thrombocytopenia in dengue infection: mechanisms and a potential application.

Khazali A, Hadrawi W, Ibrahim F, Othman S, Nor Rashid N Expert Rev Mol Med. 2024; 26:e26.

PMID: 39397710 PMC: 11488332. DOI: 10.1017/erm.2024.18.


Mechanisms of antibody-dependent enhancement of infectious disease.

Wells T, Esposito T, Henderson I, Labzin L Nat Rev Immunol. 2024; 25(1):6-21.

PMID: 39122820 DOI: 10.1038/s41577-024-01067-9.


Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism.

Liu H, Li Z, Reindl T, He Z, Qiu X, Golden R Nat Commun. 2024; 15(1):5179.

PMID: 38898037 PMC: 11187112. DOI: 10.1038/s41467-024-49161-9.


Xinyang flavivirus, from ticks in Henan Province, China, defines a basal, likely tick-only clade.

Wang L, Cheng Q, Newton N, Wolfinger M, Morgan M, Slonchak A J Gen Virol. 2024; 105(5).

PMID: 38809251 PMC: 11165663. DOI: 10.1099/jgv.0.001991.


References
1.
Randolph V, Winkler G, Stollar V . Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology. 1990; 174(2):450-8. DOI: 10.1016/0042-6822(90)90099-d. View

2.
van der Schaar H, Rust M, Waarts B, van der Ende-Metselaar H, Kuhn R, Wilschut J . Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol. 2007; 81(21):12019-28. PMC: 2168764. DOI: 10.1128/JVI.00300-07. View

3.
Vaughn D, Green S, Kalayanarooj S, Innis B, Nimmannitya S, Suntayakorn S . Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 1999; 181(1):2-9. DOI: 10.1086/315215. View

4.
Zybert I, van der Ende-Metselaar H, Wilschut J, Smit J . Functional importance of dengue virus maturation: infectious properties of immature virions. J Gen Virol. 2008; 89(Pt 12):3047-3051. DOI: 10.1099/vir.0.2008/002535-0. View

5.
Lai C, Tsai W, Lin S, Kao C, Hu H, King C . Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol. 2008; 82(13):6631-43. PMC: 2447043. DOI: 10.1128/JVI.00316-08. View